Travere Therapeutics (TVTX) PT Raised to $40 at Barclays

February 16, 2021 5:16 AM EST
Get Alerts TVTX Hot Sheet
Price: $24.95 -3.56%

Rating Summary:
    1 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 10 | New: 17
Trade Now! 
Join SI Premium – FREE
Barclays analyst Carter Gould raised the price target on Travere Therapeutics (NASDAQ: TVTX) to $40.00 while maintaining a Overweight rating.

You May Also Be Interested In

Related Categories

Analyst PT Change, Hot Comments